ABSTRACT
INTRODUCTION
A physiological pregnancy is characterized by substantial hemodynamic adaptations of the maternal cardiovascular system. Major hemodynamic changes include an increase in cardiac output, and sodium and water retention leading to plasma volume expansion, and reduction in systemic vascular resistance and systemic blood pressure [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . To accommodate the increased arterial flow, the arterial system has to adapt to keep endothelial shear rates within healthy boundaries. The mechanisms responsible for pregnancy-associated vasodilation are not yet fully understood, but it is thought to be accomplished mainly through a decrease of endothelial vascular responsiveness to the constrictors angiotensin II and norepinephrine and an increased availability of and susceptibility to the endothelium-derived relaxing factor nitric oxide (NO). Moreover estrogen and progesterone, which increase steadily during pregnancy, are also known to stimulate NO production and may account, at least partly, for the observed vascular functional adjustment [11] [12] [13] [14] .
Flow-mediated dilatation (FMD), assessed non-invasively using ultrasound, has been used widely to determine endothelial function 15 . Several studies have shown enhanced endothelial function during normal pregnancy reflected by an increased FMD and baseline brachial artery diameter (BAD) 16, 17 . Gestational hypertensive disorders (GHDs) and fetal growth restriction (FGR), as part of the placenta syndrome, are believed to be elicited by a pathological placental adaptation and/or maternal vascular vulnerability, characterized by endothelial dysfunction. The increased vascular resistance seen during GHD and FGR relates to a decreased NO production or diminished response to NO in the smooth vascular muscle indicating an underlying endothelial problem 18 . Several studies demonstrated endothelial dysfunction during GHD and FGR, also shown by a decreased FMD, when compared with uncomplicated pregnancy 19, 20 . However, endothelial adaptation to pregnancy and thereafter is uncertain. Moreover, the physiological pattern is unclear due to contradictory study results 17, 21, 22 . We hypothesized that endothelium-dependent FMD gradually increases throughout gestation. This meta-analysis aimed to review systematically and quantify current literature on endothelial adaptation during pregnancy, with FMD as the derivative, to estimate the extent of adaptation over the course of both uncomplicated and complicated pregnancy. We also aimed to construct, based on data from the included studies, reference curves for brachial FMD and BAD.
METHODS
FMD is described as a NO-and endothelium-dependent process reflecting the dilatation of an artery when exposed to reactive hyperemia 15, 23, 24 . The percentage FMD is estimated as the absolute increment in BAD after deflation of a blood pressure cuff, thus inducing hyperemia, in relation to the reference BAD 25 . A decreased FMD response reflects endothelial dysfunction and is therefore an indication of endothelial health 26, 27 .
Literature search
Studies evaluating endothelial function during uncomplicated and complicated pregnancy were searched using PubMed (NCBI) and EMBASE (Ovid). These electronic databases provided publications from 1952 and 1972, respectively, up until 9 June 2016. The search strategy focused on pregnancy, both uncomplicated and complicated, and FMD, as detailed in Table S1 . The complicated pregnancy component was subdivided into pregnancy-induced hypertension, FGR, pre-eclampsia and gestational diabetes. All components consisted of free search terms in titles and abstracts and MeSH and Emtree terms for, respectively, PubMed and EMBASE databases. Limits were set of humans and journal articles. Reference lists of all studies acquired from the electronic searches were reviewed for additional studies.
Selection of studies
Studies were qualified for inclusion following a two-phase selection process. All articles obtained from the search were screened independently for eligibility by two investigators (T.A.G.vG., V.A.L.vB.) based on title and abstract only. Articles were eligible if the method of brachial FMD measurement, as a proxy for endothelial function, was cited. Discrepancies were resolved by mutual agreement. Subsequently, the full text of articles that passed the first selection phase was reviewed for inclusion based on the inclusion and exclusion criteria by the same investigators. Studies were eligible for inclusion if they reported original data, including mean FMD (%) during human singleton pregnancy with SD, standard error (SE) or 95% CI. We assumed that FMD values were normally distributed. In addition, studies had to include a reference FMD measurement of non-pregnant, prepregnant or postpartum (≥ 6 weeks) controls. This was relevant for calculating differences between pregnant and non-pregnant FMD values within studies. Studies that did not measure FMD from the brachial artery were excluded. No restrictions were set on age, weight, height, ethnicity or parity. Additionally, studies assessing women with a pre-existing cardiovascular history or reporting data in languages other than English, Dutch, Spanish, Portuguese or German were excluded. Studies were not excluded based on the use of medication, but were excluded based on participants' smoking status. Furthermore, intervention studies, case reports and reviews were also excluded. In the case of duplicate reporting of experimental data, the most recent publication was used.
Data extraction
Data regarding study characteristics, anthropometric measures, effect measures and method used to measure brachial FMD were extracted from the selected studies. With reference to study characteristics, the following were obtained: authors, year of publication, study design, sample size, population description, inclusion and exclusion criteria, and key conclusions. Additionally, extracted subject characteristics consisted of age, non-pregnant weight and body mass index, height, parity, gravidity, body surface area, heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, gestational age at time of FMD measurement, birth weight of the offspring and gestational age at delivery. For women with a complicated pregnancy, gestational age at onset of the hypertensive disorder was also documented. Effect measures included FMD as primary outcome and BAD as a secondary outcome. Furthermore, data relating to ultrasound assessment of endothelial function were extracted as described in a tutorial by Harris et al. 23 .
Included in this tutorial were the essential elements of FMD measurements, including appropriate ultrasound technology (high-resolution, multi-frequency linear ultrasound Doppler probe, duplex mode, angle steer and insonation angle correction, electrocardiographic gating, intensity-weighted velocity calculations), subject preparation (vitamin supplementation, medications, tobacco use, caffeine, previous exercise/rested state, fasting state, adequate acclimatization, repeated measurements), baseline measurements (baseline arterial diameter and baseline blood velocity), vascular occlusion (cuff type, position and duration), reactive hyperemia measurements (temporal kinetics of arterial diameters and blood velocities and calculation of shear rate) and FMD analysis (edge detection software, calculation of FMD, normalization of FMD). Each included study was given a percentage of optimality, based on the sum of optimal items. These data were used to evaluate the quality of FMD measurement. All essential elements were of equal importance and weighted accordingly in the total score. Studies with a positive score of ≥ 60% were defined as high quality, those scoring ≥ 30% and < 60% as moderate quality and those scoring < 30% as low quality. Requests to retrieve additional information were made to the authors of the included articles if data were unclear or incomplete 20 .
Quality assessment
The quality and risk of bias of included studies were assessed independently by two investigators (T.A.G.vG., V.A.L.vB.) according to a modified set of items as reported in the Quality in Prognosis Study (QUIPS) tool 28 . This modification was made to suit the purposes of this review. A plus, minus or question mark (if this information was unknown) was allocated per study for risk of bias on five domains: study participation, study attrition, variable measurement, data reporting and study design. All domains were deemed of equal importance, and thus weighted accordingly in the total score. In case of loss to follow-up, studies were scored solely for study attrition. Studies with a positive score of ≥ 60% were defined as high quality, those scoring ≥ 30% and < 60% as moderate quality and those scoring < 30% as low quality.
Data and statistical analysis
FMD measurements were categorized into five different intervals of gestational age (< 14, 15-21, 22-28, 29-35 and 36-41 weeks). These gestational age intervals were adapted from Abudu and Sofola 29 and enabled a precise categorization of almost all available FMD measurements. FMD and diameter changes were calculated separately for these predefined intervals using a random-effects model as described by DerSimonian and Laird 30 . The SD was obtained from the SE or 95% CI and calculated for combined groups according to the Cochrane Handbook for Systematic Reviews of Interventions whenever necessary 31 . The random-effects model allows for interstudy variation and was chosen since observational data of different pregnant populations were used. Egger's regression test for funnel plot asymmetry was performed to test for the presence of publication bias 32 . The primary outcome of each study was the mean difference in FMD between the pregnancy and the reference value, and is reported with a 95% CI. In the case of a study reporting both non-pregnant controls and postpartum reference measurements, the latter was selected to reduce measurement errors. When a study provided multiple postpartum values, the last one was obtained as a reference measurement. We reported the absolute FMD increase from reference and the relative increase from reference as percentage. Some longitudinal studies reported reference and pregnant FMD of the same women 17, 20, 33, 34 . Point estimates are unaffected by these dependent observations. If the authors did not present sufficient information to determine the covariance between measurements, instead of estimating (a range of) covariance, we ignored their dependence. Since the variance of the mean difference decreases as the covariance between the two measurements increases, not taking the covariance into account can only have resulted in slightly conservative estimates of precision. The ratio between total heterogeneity and total variability (the I-squared statistic; I 2 ) was computed as a measure of heterogeneity. I 2 can distinguish true heterogeneity from sampling variance and is expressed as a percentage 35 . Sources of heterogeneity and differences between uncomplicated and complicated pregnancies were investigated by meta-regression analyses using a mixed-effects model. We considered type of reference, study quality and FMD measurement quality as sources of heterogeneity. All variables were corrected for gestational age. The meta-analyses and meta-regression analyses were performed in R version 3.2.3 using the meta package 36, 37 .
RESULTS

Study and data selection
The literature search yielded 2424 articles, after duplicate removal, from both EMBASE and PubMed electronic databases ( Figure 1 ). After screening based on title and abstract, we identified 181 studies eligible for full-article analysis. Following exclusion, largely due to the lack of FMD reference measurements of either non-pregnant or prepregnant or postpartum participants (n = 71), 14 articles were ultimately selected. Studies excluded based on study design did not measure FMD, solely reported correlations or only stated non-pregnant and postpartum brachial FMD measurements. Additionally, one article was excluded due to suspicion of duplicate reporting 38 , while five other articles were excluded because of unobtainable data from abstracts [39] [40] [41] [42] [43] . One article was excluded based on FMD measurement method, due to measurement of the radial artery rather than the brachial artery 44 . We did not find any other studies after screening reference lists (Table S2) . For all included studies reporting more than one dataset, only data with an eligible reference value 45 , FMD measurement value 20 and cross-sectional data 17 were included. Several studies included both non-pregnant and postpartum controls 16, 34 . One study reported FMD data in healthy children and adults of both gender with and without a history of stroke or coronary heart disease and healthy pregnant women.
Only the FMD values of healthy pregnant women were included along with the reference FMD 45 . In another study, FMD data were presented in active pregnant, sedentary pregnant, active non-pregnant and sedentary non-pregnant women, but solely the combined data of pregnant and non-pregnant women were included 21 .
In a study consisting of non-smokers and smokers, only non-smoker FMD data were included because of the known negative effect of smoking on endothelial function 46 . The 14 articles selected for analysis included 387 non-pregnant, 542 healthy pregnant, 223 postpartum and 79 GHD FMD women.
Characteristics
Study characteristics and anthropometric measures of study participants included in this review and meta-analysis are described in Tables 1 and 2 , for uncomplicated pregnancies and pregnancies complicated by GHD, respectively. For most studies, overall characteristics are presented, since these did not report subgroup characteristics. Pregnancies complicated by pre-eclampsia 47, 48 and gestational hypertension 20 were indexed as pregnancies complicated by GHD.
Data extraction
Participants' anthropometric data were insufficiently and infrequently reported by the authors. It was therefore impossible to analyze the contribution of these variables to the heterogeneity observed.
Quality assessment
Quality assessment of included studies was subdivided into high quality (n = 2), moderate quality (n = 10) and low quality (n = 2) as illustrated in Table S3 . Outcome scores varied between 24% and 65% (median 47%; IQR 37-53%). All studies fulfilled two items: clear reporting of gestational age and an equal method and setting for all study participants throughout follow-up. All but three 45, 48, 49 studies stated a mean for the gestational age at measurement, and these data were provided later by the author of one article 49 . Items that scored lowest were a prepregnant FMD value as reference and adequate description of ethnicity, no studies reporting on these items.
FMD quality assessment of included studies was subdivided into moderate quality (n = 4) and low quality (n = 10) studies, with no high quality studies (Table S4) . Outcome scores varied between 4% and 42% (median 23%; IQR 17-32%). These scores were predominantly the result of insufficient and/or absence of First author only given for each study. Parity and gravidity data are in normal and italic font, respectively. Reference (R) FMD was measured in non-pregnant (NP) or postpartum (PP) controls. During physiological pregnancy (P), FMD was measured at different gestational ages. First author only given for each study. Reference (R) FMD was measured in non-pregnant (NP) or postpartum (PP) controls. During GHD pregnancy, FMD was measured at 34 and 35 weeks of amenorrhea.
data reporting method, rather than elements not being optimal.
The meta-regression analysis, to interpret heterogeneity, in terms of study-level covariates, showed a significant statistical association between FMD course and different study qualities (low quality study (LQ) vs moderate quality study (MQ) vs high quality study (HQ); 0.06 ≤ P ≤ 0.02). There was no significant effect of gestational age on the course of FMD measurement (P = 0.07). The FMD measurement quality was not significant (P = 0.38), nor was the type of reference measurement (postpartum vs non-pregnant controls; P = 0.92).
The meta-regression analysis for BAD showed a significant effect of gestational age (P = 0.02), indicating a considerable increase during the course of pregnancy. There was no effect on the BAD course and different study qualities (LQ vs MQ vs HQ; 0.15 ≤ P ≤ 0.19), nor the type of reference measurement (postpartum vs non-pregnant controls; P = 0.66) or FMD measurement quality (P = 0.09).
Flow-mediated dilatation
Between 15 and 21 weeks of gestation, absolute FMD showed the greatest increase of 1.89% (0.25-3.53%). This was a relative increase of 22.5% (3.0-42.0%) compared with reference FMD. The highest increase in FMD disclosed in this review was 7.27% (4.22-10.32%), which was substantially larger compared with the other studies in this category 33 . The fact that, in this review, the greatest reported increase was in the second trimester, and, more importantly, a specific study 33 showed a 45 8 24
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Change in FMD (%) substantially larger effect than the other articles, raised a concern regarding its influence on the mean percentage increase during this interval. Thus, a subanalysis of the forest plots was performed without this particular study and still resulted in a significant increase of 1.05% (0.09-2.02%) during the 15-21-week interval. One study reported FMD data between 14 and 16 weeks' gestation and was allocated to this interval in the analysis 45 . Forest plots of the FMD course throughout uncomplicated pregnancy compared with reference values are depicted in Figure 2 . Funnel plot asymmetry was not statistically significant at any interval (0.22 ≤ P ≤ 0.62). FMD was 48 Saarelainen (2012) 20 Yamamoto (2010) 47 Summary increased to a lesser degree of 0.94% (0.00-1.88), relative 10.4% (0.0-20.7%), in the second half of the second trimester at 22-28 weeks' gestation. At 29-35 weeks of pregnancy, FMD was increased by 1.24% (0.29-2.19%), relative 13.9% (3.3-24.6%), which was greater than the previous interval, but less than the first half of the second trimester. Most studies reported data for this interval. The greatest increase in FMD reported in this category was 5.40% (2.07-8.73%). No increase was seen between 36 and 41 weeks' gestation compared with reference conditions. One study reported FMD data between 32 and 39 weeks' gestation and was allocated to the last interval in the analysis 45 .
A forest plot of the FMD course during pregnancies complicated by GHD compared with reference values is illustrated in Figure 3 . Included studies report data on FMD during complicated pregnancies between 29 and 35 weeks. There was no significant increase in FMD, 1.02% (−0.5 to 2.5%), relative 11.9% (−5.8 to 29.5%), between 29 and 35 weeks of gestation compared with reference values, nor was this different from uncomplicated pregnancies (P = 0.77).
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Miyague (2013) 34 Quinton (2007) ( Figure 4 ). Each point estimate was indexed as a value from a low-, moderate-or high-quality study as stipulated by study quality assessment.
Brachial artery diameter
When compared with reference conditions, BAD increased significantly, in a progressive manner, during the intervals 22-28, 29-35 and 36-41 weeks' gestation with values of, respectively, 0.13 mm (0.03-0.23 mm), relative 4.2% (0.9-7.4%); 0.20 mm (0.15-0.26 mm), relative 6.5% (4.8-8.4%); and 0.24 mm (0.09-0.40 mm), relative 7.7% (2.9-12.8%). Forest plots of the BAD course throughout uncomplicated pregnancy and pregnancy with GHD compared with the reference value are depicted in Figures 5 and 6 , respectively. Funnel plot asymmetry was detected at 22-28 weeks' gestational age in healthy pregnancies (P = 0.03). However, the 
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Saarelainen (2012) 20 Yamamoto (2010) 47 Summary pooled estimate remained 0.13 mm after correction, using the trim and fill method 50 . No other funnel plot asymmetry was found (0.38 ≤ P ≤ 0.77). In pregnancies complicated by GHD, BAD increased significantly by 0.31 mm (0.11-0.50 mm), relative 10.0% (3.5-16.1%), at 29-35 weeks of gestation 20, 47 when compared with reference measurements. No significant differences in BAD measurements were detected between healthy pregnancies and pregnancies complicated by GHD in this specific interval (P = 0.25). Figure 7 illustrates reference values for BAD throughout physiological, uncomplicated pregnancy, similar to FMD in uncomplicated pregnancies, with the absolute course of the mean, and 5 th and 95 th percentiles, of non-pregnant, healthy pregnant and postpartum measurements, portraying intrastudy variances.
DISCUSSION
In this meta-analysis we reviewed systematically the adaptation of FMD and BAD throughout pregnancy. In uncomplicated pregnancies, FMD was increased in the second and third trimesters. BAD increased progressively in a steady manner but did not reach significance in the first half of the second trimester. In pregnancies complicated by GHD, both BAD and FMD were not significantly different compared with healthy pregnancy.
Pregnancy is characterized by profound vasodilatation 51 . Throughout gestation, extensive hemodynamic adaptations occur, by way of plasma expansion and increase in cardiac output, instigated by an abrupt and profound reduction in peripheral vascular resistance 51 .
These adaptations cause an increase in shear stress on the vascular endothelium, thereby triggering vascular reactivity to self-regulate tone. In contrast, pregnancy-induced hemodilution and a decreased blood viscosity lower shear forces upon the endothelium 52 . Subsequently, local endothelial mechanisms induce a vasomotor response by means of vasodilatation in functionally intact endothelium, as observed in conduit arteries, designated as FMD 24, 53 . The exact system for detecting an increase in shear stress is believed to be related to calcium-activated potassium channels that react by shifting to an open conformation, hyperpolarizing the endothelial cell and subsequently causing calcium to enter the cell 24, [54] [55] [56] [57] . As such, calcium activates endothelial nitric oxide synthase leading to NO synthesis.
Physiologically, adequate endothelial function exhibits balance and local regulation of anti-inflammatory, antithrombotic, anticoagulant, profibrinolytic, antihypertrophic and endothelium-dependent vasodilatation characteristics [58] [59] [60] . A dysfunctional endothelium can be non-invasively evaluated by assessing the endothelium-dependent vasodilatation, a measurement also feasible during pregnancy. The change in vasodilatory response during pregnancy may be reflected by an increase in FMD. We observed that on top of the progressively increasing BAD, FMD is increased in the second half of pregnancy, a finding in line with several longitudinal studies 16 . The fact that FMD does not rise steadily throughout gestation could be the result of the progressively increasing BAD. Considering that smaller vessels have a more profound FMD response to a stimulus than do larger vessels, it is striking that increased FMD coincides with increased BAD during pregnancy [61] [62] [63] . Moreover, when stretched, the elastic properties of the same vessel respond differently, usually towards more stiffening. Interestingly, even though vascular function is increased during pregnancy, we found no indication that vessel structure is permanently changed, as both function and structure return to similar levels after pregnancy. This is in contrast to studies indicating that an increased function could result in structural adaptation 64, 65 . As mentioned, the increase in flow-mediated response is not directly proportional to baseline diameter, making it baseline diameter dependent. An allometric model involving FMD (on a log scale) as the outcome and BAD (log-transformed) as a covariate has been proposed to resolve this dependency 66 . However, we could not investigate this dependency in this meta-analysis. Besides mechanical effects, increased gestation-induced low-grade inflammation may affect FMD. The maternal inflammatory response in late pregnancy is suggested to relate to changes in FMD due to diminished NO-mediated dilatation 19 . Maladaptation of maternal vascular and central hemodynamic function in pregnancy may affect remodeling of arteries and with it trophoblastic invasion, creating an imbalance in the maternal-fetal interface. These adverse adjustments may result in additional endothelial impairment. Clinically, this impairment manifests in placental dysfunction and induced FGR on the one hand, and maternal capillary-leak-induced edema, organ hypoperfusion, hypertension, proteinuria, platelet activation and consumption, and erythrocyte decay on the other 67, 68 . Recently, a large meta-analysis reported a lower FMD before the clinical onset and during pre-eclampsia compared with uncomplicated pregnancy 69 . We were unable to confirm those findings, mainly due to our different objective for which we had to include only studies using a non-pregnant reference value within the same study. However, when we compare mean FMD values of the studies included in that review with the reference values computed by our study, they are all below the 50 th percentile and more than half are below the 25 th percentile. Pitfalls and discrepancies that could have resulted in the dispersion of non-pregnant FMD values can be found in methodological shortcomings of included studies. According to Weissgerber et al. 21 , continuous FMD diameter measurements are required to adjust for delayed peak dilatation in pregnancy, since post-release diameter at 60 s differs significantly from that in non-pregnant women which peaks on average at 45 s. Other methodological shortcomings within studies, such as caffeine use, menstrual phase used as reference, fasting state and adequate acclimatization, could also be responsible for the broad interval between the 5 th and 95 th percentiles. Regarding the detected funnel plot asymmetry in physiological pregnancies during gestational age of 22-28 weeks, the results should be interpreted with caution. Even though the trim and fill method provided an identical estimate, no presuppositions should be made considering that the mechanism for publication bias is unknown and rationales other than this specific bias could have elicited funnel plot asymmetry 31 . According to Egger et al., the capacity to ascertain publication bias is restricted when meta-analysis consists solely of limited and/or small studies, as was the case in our study 32 . Limitations of this study should be acknowledged. First, our meta-analysis was based on a relatively limited number of studies, mostly due to the necessity of a non-pregnant reference measurement within the studied population. This could have resulted in a lower statistical power because of numbers, but increased validity because of the use of the same measurement techniques. Second, authors reported participants' anthropometric data insufficiently and infrequently. It was therefore impossible to analyze the contribution of these variables to the heterogeneity observed. Third, methodological shortcomings within and disparities between studies have limited data interpretation, which is reflected by our meta-regression analysis, which exhibited a significant effect on the regression when study quality was taken into account. Groups overlap due to the combination of extensive spreading of non-pregnant FMD values and broad reference interval of pregnant women. This implies that, in clinical practice, no conclusion can be drawn based on a single FMD measurement, but serial assessments within an individual may detect alterations in their endothelial function that could be of value in clinical practice.
In conclusion, this review and meta-analysis was systematically conducted to summarize and evaluate current literature on the extent of physiological and pathological endothelial adaptation throughout pregnancy. During healthy pregnancy, endothelium-dependent vasodilatation and brachial artery diameter are increased. Women with a complicated pregnancy fell within the lower range of FMD values when compared with those with uncomplicated pregnancies, but as a group they did not differ from each other. A lack of serial assessments impeded an adequate comparison with the course of adaptation of uncomplicated pregnancy.
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